A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack

This study has been terminated.

Study NCT00112281 Information provided by Arginox Pharmaceuticals

First Received: June 1, 2005 Last Updated: August 2, 2006 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	January 2007
Estimated Primary Completion Date:	No date given